Pharmafile Logo
Pharmafocus logo
Advanced Search
Zytiga image

Zytiga extended in EU

January 15, 2013
Sales and Marketing EU, J&J, JJ, Janssen, Zytiga

Janssen is celebrating the European Commission’s decision to extend the licence for its prostate cancer treatment Zytiga. The once-daily pill …

News

Pharma manufacturing news in brief

January 14, 2013
Manufacturing and Production ADMA, Biotest, Catalent, Emerson, Nanocarrier, Orient Europharma, UCB

Facility news from Orient Europharma/NanoCarrier, Catalent and China Biologic, plus new contracts for Emerson Process Management and Biotest Pharma.

News
FDA Hamburg image

FDA publishes guidance on abuse-resistant opioids

January 14, 2013
Manufacturing and Production CDC, FDA, hamburg, opioids

The US Food and Drug Administration has issued draft guidance designed to combat the escalating problem of abuse of prescription …

News
lonza image

Lonza earmarks $15m for ADC plant expansion

January 14, 2013
Manufacturing and Production ADC, API, Lonza, Novasep

Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in new capacity for antibody drug …

News
screen_shot_2013-01-14_at_13

Kathryn Gallant joins Insight Health US as joint chief executive

January 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gallant, insight health

The former managing partner for US health at Hall & Partners has joined the consultancy firm Insight Health US as …

Appointment
Eisai image

Eisai cancer drug fails

January 14, 2013
Research and Development, Sales and Marketing Cancer, Eisai, Morphotek, farletuzumab

Eisai’s investigational oncology treatment farletuzumab has failed to reach its primary endpoint in a late-stage trial. Farletuzumab (MORAb-003) did not …

News
merck_incweb

Merck withdraws Tredaptive

January 14, 2013
Sales and Marketing EMA, Merck, tredaptive

Merck is mounting a global operation to withdraw its cholesterol-lowering drug Tredaptive from the market following safety concerns. The company …

News
screen_shot_2013-01-11_at_10

Dominic Atkins joins Clinigen GAP in senior commercial role

January 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Clinigen, Dominic Atkins

Pharma services company Clinigen Global Access Programs (Clinigen GAP) has appointed Dominic Atkins as global business development director. In this …

Appointment
janssen image

Janssen’s diabetes drug Invokana recommended

January 11, 2013
Sales and Marketing Janssen, SGLT2, canagliflozin, diabetes, invokana

An FDA advisory committee has recommended Janssen’s new diabetes treatment canagliflozin for approval. To be marketed under the name Invokana, …

News
GSK image

EU submission for GSK and Theravance COPD drug

January 11, 2013
Sales and Marketing COPD, GSK, Theravance, UMEC/VI

GlaxoSmithKline and Theravance have submitted their chronic obstructive pulmonary disease (COPD) drug UMEC/VI to European regulators. The application follows the …

News
screen_shot_2013-01-11_at_09

Lundbeck appoints new global pricing and market access VP

January 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eggert, Jaszewski, Lundbeck

Barbara Jaszewski, has been appointed vice president of global pricing and market access at Lundbeck. She will be in charge …

Appointment

Public health budget ring-fenced

January 11, 2013
Sales and Marketing Hunt, NHS, government

Local authorities are to receive a total of £5.45 billion from the government over the next two years to spend …

News
1301che_dr_abdulmajeed_raji

Cherwell appoints product specialist

January 11, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Cherwell Laboratories

Pharma supplier firm Cherwell Laboratories has announced the appointment of Abdulmajeed Raji as microbiology product specialist. Prior to joining Cherwell, …

Appointment
FDA image

FDA vote on J&J diabetes drug

January 10, 2013
Sales and Marketing EU, FDA, J&J, JJ, Janssen, canagliflozin

Key advisers to the FDA are meeting today to decide whether Janssen Pharmaceuticals’ type II diabetes drug canagliflozin is safe …

News
thomas_monarth

Hookipa Biotech hires two officers

January 10, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Farshad Guirakhoo, Hookipa, Thomas Monarth

Vaccines biotech firm Hookipa Biotech AG has appointed two new members to its management team. Thomas Monath (pictured) joins as …

Appointment

Global agency network welcomes new members

January 10, 2013
Medical Communications Indigenus, Lindh & Partners, PharMa International

A global network of independent healthcare agencies has welcomed two new members to the group. Tokyo-based PharMa International and Swedish …

News
Hunt image

£120m health research boost

January 10, 2013
Sales and Marketing Hunt, NHS, NIHR, TXA

The Department of Health is putting £120 million of new funding into health research over the next five years in …

News
Dorrell image

CQC ‘needs urgent overhaul’, say MPs

January 9, 2013
Sales and Marketing CQQ, Dorrell, NHS, select committee

England’s health and social care regulator, the Care Quality Commission (CQC), must overhaul its governance structures ‘as a matter of …

News
Gilead image

Gilead licences MacroGenics technology

January 9, 2013
Research and Development, Sales and Marketing DART, Gilead, MacroGenics

Private biotech company MacroGenics has licenced its bi-specific antibody platform technology to Gilead Sciences for products aimed at four unnamed …

News
prne-mapigroup-jamesmkaris-1y-2high

MAPI Group hires James Karis as chief executive

January 9, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing James Karis, MAPI

Healthcare services group MAPI has named James Karis as its chief executive. MAPI looks to Karis to consolidate its success …

Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026